Edition:
United States

Denali Therapeutics Inc (DNLI.OQ)

DNLI.OQ on NASDAQ Stock Exchange Global Select Market

19.77USD
20 Apr 2018
Change (% chg)

$0.51 (+2.65%)
Prev Close
$19.26
Open
$19.17
Day's High
$19.84
Day's Low
$19.17
Volume
31,242
Avg. Vol
113,773
52-wk High
$25.50
52-wk Low
$14.80

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.00 -0.223
Sep '17 0.00 -0.265
Jun '17
FY 2016 Dec '16 0.00 -0.235
Sep '16 0.00 -0.371
Jun '16
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 2 0.00 0.00 0.00 --
Quarter Ending Sep-18 3 0.00 0.00 0.00 --
Year Ending Dec-18 3 50.00 55.00 45.00 --
Year Ending Dec-19 4 70.00 200.00 0.00 --
Earnings (per share)
Quarter Ending Jun-18 2 -0.21 -0.16 -0.26 --
Quarter Ending Sep-18 2 -0.19 -0.11 -0.28 --
Year Ending Dec-18 3 -0.63 -0.52 -0.76 --
Year Ending Dec-19 3 -1.35 -1.13 -1.48 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 188.22 33.60
P/E High - Last 5 Yrs. -- 284.72 45.95
P/E Low - Last 5 Yrs. -- 95.76 24.93
Beta -- 0.75 0.80
Price to Sales (TTM) -- 136.15 7.07
Price to Book (MRQ) 3.71 19.54 5.13
Price to Tangible Book (MRQ) 4.01 24.07 6.73
Price to Cash Flow (TTM) -- 122.99 25.52
% Owned Institutions 73.33 11.18 2.22

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.51
Dividend Yield - 5 Year Avg -- 0.20 0.75
Dividend 5 Year Growth Rate -- 1.94 3.93
Payout Ratio(TTM) -- 9.18 20.35

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 103.73 9.02
Sales (TTM) vs TTM 1 Yr. Ago -- 79.72 10.83
Sales - 5 Yr. Growth Rate -- 33.87 8.21
EPS (MRQ) vs Qtr. 1 Yr. Ago 5.05 -66.87 22.25
EPS (TTM) vs TTM 1 Yr. Ago 3.43 -- --
EPS - 5 Yr. Growth Rate -- 47.46 10.26
Capital Spending - 5 Yr. Growth Rate -- 45.48 10.37

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.63 2.53
Current Ratio (MRQ) 28.92 5.97 3.62
LT Debt to Equity (MRQ) 0.00 23.32 11.31
Total Debt to Equity (MRQ) 0.00 25.75 13.97
Interest Coverage (TTM) -- -186.61 30.11

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 36.56 54.01
Gross Margin - 5 Yr. Avg. -- 55.38 52.12
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -152.18 15.89
Operating Margin (TTM) -- -563.03 4.33
Operating Margin - 5 Yr. Avg. -- -164.18 11.25
Pre-Tax Margin (TTM) -- -535.84 4.97
Pre-Tax Margin - 5 Yr. Avg. -- -171.12 11.56
Net Profit Margin (TTM) -- -524.81 1.58
Net Profit Margin - 5 Yr. Avg. -- -171.01 7.89
Effective Tax Rate (TTM) -- -0.44 31.30
Effective Tax Rate - 5 Yr. Avg. -- 18.14 24.27

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 23,887,722 816,988,634
Net Income/Employee (TTM) -678,346 956,935 96,050,323
Receivable Turnover (TTM) -- 6.24 5.56
Inventory Turnover (TTM) -- 2.37 3.45
Asset Turnover (TTM) -- 0.40 0.89

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -0.77 10.54
Return on Assets - 5 Yr. Avg. -- 0.70 11.56
Return on Investment (TTM) -- -0.74 13.19
Return on Investment - 5 Yr. Avg. -- 4.20 14.97
Return on Equity (TTM) -- -2.80 15.00
Return on Equity - 5 Yr. Avg. -- -0.05 16.25
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 4.11 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Denali Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -7.36 -10.20 31 9
13 Week 0.05 5.30 62 72
26 Week -- -- -- 89
52 Week -- -- -- 77
YTD 26.41 26.57 78 88
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 73.34%
# of Holders: 56
Total Shares Held: 69,254,426
3 Mo. Net Change: 607,733
# New Positions: 10
# Closed Positions: 1
# Increased Positions: 10
# Reduced Positions: 1
# Net Buyers: 9
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.